Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | TSHR | P16473 | 3/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopentane SCHEMBL29146082 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TSHRTDP1HSD17B10LMNA | |
| SCHEMBL523 | 0.88 | — | — | |
| SCHEMBL1331977 | 0.88 | — | — | |
| SCHEMBL9866292 | 0.88 | — | — | |
| SCHEMBL1331774 | 0.88 | — | — | |
| SCHEMBL1330344 | 0.88 | — | — | |
| SCHEMBL5305593 | 0.88 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1HSD17B10LMNA | |
| SCHEMBL4137877 | 0.84 | — | — | |
| SCHEMBL6063757 | 0.84 | — | — | |
| SCHEMBL431680 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114127045-B | Method for producing diacyl peroxide | 诺力昂化学品国际有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-119039172-A | N, N ', N ' ' -triacyl-1, 3, 5-tri (p-aminophenyl) benzene compound, preparation method and application | 北京理工大学 | 2024-11-29 | — | — | CN | disclosed |
| CN-111108642-B | Nonaqueous electrolyte, nonaqueous electrolyte secondary battery, and energy device | 三菱化学株式会社 | 2024-04-02 | — | — | CN | disclosed |
| CN-117790904-A | Nonaqueous electrolyte, nonaqueous electrolyte secondary battery, and energy device | 三菱化学株式会社 | 2024-03-29 | — | — | CN | disclosed |
| CN-111628217-B | Electrolyte for lithium ion secondary battery, and assembly | 丰田自动车株式会社 | 2023-12-15 | — | — | CN | disclosed |
| CN-116057745-A | Nonaqueous electrolyte and power storage device using same | MU电解液株式会社 | 2023-05-02 | — | — | CN | disclosed |
| EP-2738156-B1 | 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUNDS | KBP BIOSCIENCES USA INC (US) | 2018-01-03 | — | — | EP | disclosed |
| US-9365499-B2 | 9-aminomethyl substituted tetracycline compounds | KBP BIOSCIENCES CO., LTD. (CN) | 2016-06-14 | — | — | US | disclosed |
| US-20140179638-A1 | 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUNDS | KBP BIOSCIENCES CO., LTD. (CN) | 2014-06-26 | — | — | US | disclosed |
| EP-2738156-A1 | 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUND | KBP Biosciences Co., Ltd. (CN) | 2014-06-04 | — | — | EP | disclosed |
| US-6265573-B1 | Purification process | SCHLUMBERGER TECHNOLOGY CORPORATION | 2001-07-24 | — | — | US | disclosed |
| US-6214988-B1 | BY PROVIDING A GRANULE COMPRISING ALPHA-HMX (1,3,5,7-TETRANITRO-1,3,5,7-TETRAAZACYCLOOCTANE) PARTICLES AND WHICH HAS INTERNAL VOID SPACES, AND SORBING AT LEAST ONE SECOND MATERIAL INTO THE VOID SPACES; MAKING SHAPED ARTICLE | SCHLUMBERGER TECHNOLOGY CORPORATION | 2001-04-10 | — | — | US | disclosed |
| EP-1086973-A2 | Polyimide gas separation membranes | PRAXAIR TECHNOLOGY, INC. (US) | 2001-03-28 | — | — | EP | disclosed |
| US-6201117-B1 | REACTING 3,7-DIALKANOYL-1,3,5,7-TETRAAZABICYCLO(3.3.1)NONANE WITH AN ALKANOIC ACID ANHYDRIDE TO FORM A 1,3,5-TRIALKANOYL-7-ALKANOYLOXYMETHYL-1,3,5,7-TETRAAZACYCLOOCTANE AND REACTING THAT WITH THE ANHYDRIDE IN WATER AND METAL OXIDE; EXPLOSIVES | SCHLUMBERGER TECHNOLOGY CORPORATION | 2001-03-13 | — | — | US | disclosed |
| US-6194571-B1 | MIXING 1-(N)-ACETYL-3,5,7-TRINITRO-CYCLOTETRAMETHYLENETETRAMINE) WITH NITRIC ACID, ADDING PHOSPHOROUS PENTOXIDE TO CAUSE SOLID-STATE NITRATION TO PRODUCE OCTOGEN | SCHLUMBERGER TECHNOLOGY CORPORATION | 2001-02-27 | — | — | US | disclosed |
| WO-2000073285-A1 | PROCESS FOR MAKING AN HMX PRODUCT | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000073246-A1 | GRANULATION PROCESS | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000073245-A2 | PROCESS FOR COATING AND IMPREGNATING HMX WITH ADDITIONAL MATERIALS | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000073286-A1 | HMX COMPOSITIONS AND PROCESSES FOR THEIR PREPARATION | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2000-12-07 | — | — | WO | disclosed |
| US-4164508-A | USED AS ANTISTATIC AGENTS AND MONOMERS FOR TEXTILES | Snia Viscosa Societa' Nazionale Industria Viscosa S.p.A. (IT) | 1979-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179638-A1 | 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUNDS | TET3, TET1, PRMT9 | ALDH1A1 3143/4885TSHR 912/4885TDP1 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.